AbCellera Biologics Inc.
ABCL | NASDAQ
$12.72
+$0.06 (+0.47%)
Sep 22, 2026, 12:33 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 128.51M | 156.33M | 133.32M | 386.54M | 476.14M | 594.12M |
Short-Term Investments | 405.31M | 469.29M | 627.27M | 499.95M | 246.84M | n/a |
Long-Term Investments | 62.58M | 82.3M | 65.94M | 72.52M | 50.31M | 20.03M |
Other Long-Term Assets | 51.95M | 96.54M | 94.24M | 41.03M | 23.23M | 1.71M |
Receivables | 153.4M | 92.13M | 64.38M | 103.41M | 174.86M | 213.73M |
Inventory | 6.34M | n/a | 1.11M | 1.53M | 1.67M | 1.41M |
Other Current Assets | 34.67M | 33.63M | 45.91M | 25M | 25M | n/a |
Total Current Assets | 728.23M | 751.37M | 871.99M | 1.03B | 929.8M | 813.33M |
Property-Plant & Equipment | 428M | 340.43M | 287.7M | 217.26M | 111.62M | 17.92M |
Goodwill & Intangibles | 86.19M | 89.92M | 168.23M | 179.31M | 196.2M | 146.65M |
Total Long-Term Assets | 628.72M | 609.18M | 616.11M | 515.42M | 388.77M | 192.21M |
Total Assets | 1.36B | 1.36B | 1.49B | 1.54B | 1.32B | 1.01B |
Account Payables | 25.23M | 34.35M | 25.51M | 14.83M | 14.92M | 7.32M |
Deferred Revenue | 22.51M | 21.18M | 18.96M | 21.61M | 7.54M | 7.53M |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | 190K |
Other Current Liabilities | n/a | 8.09M | 60.68M | 69.84M | 54.85M | 9.08M |
Total Current Liabilities | 64.31M | 76.61M | 119.01M | 118.32M | 120.68M | 103.49M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | 2.2M |
Other Long-Term Liabilities | 4.77M | 1.47M | 10.82M | 19.14M | 37.62M | 13.57M |
Total Long-Term Liabilities | 325.74M | 227.86M | 216.76M | 189.31M | 172.16M | 71.54M |
Total Liabilities | 390.05M | 304.47M | 335.78M | 307.63M | 292.84M | 175.03M |
Total Debt | 143.22M | 65.36M | 77.38M | 82.26M | 40.07M | 6.78M |
Book Value | 966.9M | 1.06B | 1.15B | 1.23B | 1.03B | 830.51M |
Book Value Per Share | 3.24 | 3.59 | 3.98 | 3.92 | 3.22 | 3.16 |
Common Stock | 802.34M | 777.17M | 753.2M | 734.37M | 722.43M | 710.39M |
Retained Earnings | -29.48M | 116.93M | 279.79M | 426.19M | 267.67M | 114.2M |
Comprehensive Income | -4.23M | -4.38M | -1.72M | -1.39M | 280K | n/a |
Shareholders Equity | 966.9M | 1.06B | 1.15B | 1.23B | 1.03B | 830.51M |
Total Investments | 467.89M | 551.59M | 693.2M | 572.47M | 297.15M | 20.03M |
Add to Watchlist
Select watchlists to add or remove ABCL